Ghost Pharmacists in the Philippines: A Critical Analysis of Professional Accountability, Patient Safety, and Leadership
Main
Emil Arca*
Ghost pharmacist practice in the Philippines presents ethical, professional, regulatory, and leadership concerns because the use of a pharmacist’s credentials without genuine professional presence creates a gap between formal regulatory compliance and actual professional responsibility. The primary objective of this critical analysis is to examine ethical and professional issues, stakeholder responsibilities, leadership response, patient access and regulatory enforcement, potential root causes, professional accountability, and public trust. Institutional Theory, Professional Ethics Theory, and Systems Theory provide complementary lenses for examining the institutional, professional, organizational, and systemic dimensions of the practice. The analysis indicates that ghost pharmacist practice cannot be adequately examined as individual misconduct alone, as organizational practices, regulatory oversight, commercial pressures, and professional conditions may also influence its persistence. However, these factors should not be interpreted as direct causes where empirical evidence is limited. Professional accountability extends to pharmacists and to organizations responsible for pharmacy operations, while regulatory authorities have responsibilities for effective oversight and enforcement. Appropriate responses require evidence-based investigation, due process, and proportionate enforcement while protecting legitimate patient access to medicines. Genuine pharmacist presence, appropriate staffing, organizational safeguards, confidential reporting, and consistent regulatory oversight may strengthen professional accountability and reduce opportunities for nominal compliance. Addressing ghost pharmacist practice therefore requires coordinated responses across professional, organizational, institutional, and system levels, with patient welfare as the primary consideration in pharmacy practice, leadership, and regulatory decision-making.
Abbott, A. (1983). Professional Ethics. American Journal of Sociology, 88(5), 855–885. https://doi.org/10.1086/227762
Amenta, E., & Ramsey, K. M. (2010). Institutional Theory. In Handbooks of Sociology and Social Research (pp. 15–39). Springer New York. https://doi.org/10.1007/978-0-387-68930-2_2
Ball, D., & Salenga, R. (2017). Pharmaceutical Policy in the Philippines. In Pharmaceutical Policy in Countries with Developing Healthcare Systems (pp. 45–73). Springer International Publishing. https://doi.org/10.1007/978-3-319-51673-8_4
Carandang, R. R., Gumop‐as, J. G., Andoloy, S. R., Daguman, F. L., Jose, L. J., Villarino, M., & Quilala, P. (2024). Barriers and Facilitators on Pharmacovigilance Practice Among Pharmacists in Metro Manila, Philippines. Pharmacoepidemiology and Drug Safety, 33(12), e70072. https://doi.org/10.1002/pds.70072
Carandang, R. R., Puguon Jr., F., Santos, M. L., Ilagan, E., Gamboa, K. G., & Aquino, J. G. (2024). Burnout and Turnover Intention Among Community and Hospital Pharmacists in Metro Manila, Philippines. Merits, 4(4), 463–474. https://doi.org/10.3390/merits4040033
Cristuta, S. M. N., & Cesar, J. H. A. (2024). Adherence towards good pharmacy practice of community pharmacists in central Visayas, Philippines. International Journal of Pharmacy Practice, 32(Supplement_2), 51–52. https://doi.org/10.1093/ijpp/riae058.061
Fathelrahman, A. I., Ibrahim, M. I. M., & Wertheimer, A. (2016). Pharmacy Practice in Developing Countries: Achievements and Challenges. Elsevier.
FDA. (2009). Drugstore Initial: Declaration & Undertaking. Food and Drug Administration Philippines. https://eservices.fda.gov.ph/applications/license_to_operate/drug/drugstore
Fino, L. B., Basheti, I. A., Saini, B., Moles, R., & Chaar, B. B. (2020). Exploring pharmacy ethics in developing countries: a scoping review. International Journal of Clinical Pharmacy, 42(2), 418–435. https://doi.org/10.1007/s11096-020-01021-4
Gallego Jr., M., Caparro, D., Macorol, R., Manalastas, T. J., & Olaivar, C. A. (2024). A Quantitative Study into Purchasing Practices and Influential Factors among Filipino Consumers Regarding Counterfeit Over-The-Counter Medicines in Philippines. The Eurasia Proceedings of Science Technology Engineering and Mathematics, 28, 123–133. https://doi.org/10.55549/epstem.1519352
Goode, J.-V., Owen, J., Page, A., & Gatewood, S. (2019). Community-Based Pharmacy Practice Innovation and the Role of the Community-Based Pharmacist Practitioner in the United States. Pharmacy, 7(3), 106. https://doi.org/10.3390/pharmacy7030106
Gregory, P. A. M., Seuthprachack, W., & Austin, Z. (2020). Community pharmacists’ perceptions of leadership. Research in Social and Administrative Pharmacy, 16(12), 1737–1745. https://doi.org/10.1016/j.sapharm.2020.02.001
Hartigan-Go, K. (2012). Challenges of Drug Risk Communications in the Philippines. Drug Safety, 35(11), 995–1004. https://doi.org/10.2165/11635920-000000000-00000
Hussain, A., & Jamshed, S. (2016). Pharmacy Practice in Pakistan. In Pharmacy Practice in Developing Countries (pp. 97–115). Elsevier. https://doi.org/10.1016/b978-0-12-801714-2.00006-x
Ibrahim, M. I. M., Fathelrahman, A. I., & Wertheimer, A. I. (2016). Comparative Analysis and Conclusion. In Pharmacy Practice in Developing Countries (pp. 449–467). Elsevier. https://doi.org/10.1016/b978-0-12-801714-2.00020-4
Javadi, M., Ashrafi, N., & Salari, P. (2018). Assessment of Pharmacists Experiences and Attitudes Toward Professionalism and Its Challenges in Pharmacy Practice. Iranian Journal of Pharmaceutical Research, 17, 168–177. https://doi.org/10.22037/ijpr.2018.2245
Johar, H. F., Aldi, Y., Nasif, H., & Fitria, N. (2026). Impact of Pharmacist Counseling on Peptic Ulcer Disease Patients Based on Evidence From SERVQUAL Evaluation. Asian Journal of Pharmaceutical and Clinical Research, 17, 65–70. https://doi.org/10.22159/ajpcr.2026v19i3.58040
Poudel, B. K., Ishii, I., & Khakurel, B. (2016). Assessment of regulatory compliance in selected pharmacy outlets of Nepal. Journal of Pharmaceutical Health Services Research, 7(1), 31–36. https://doi.org/10.1111/jphs.12127
Professional Regulatory Board of Pharmacy. (2021). Resolution No. 23, Series of 2021: Resolution Promulgating and Prescribing the Code of Ethics of the Pharmacy Profession. Professional Regulation Commission. https://www.prc.gov.ph/sites/default/files/ResoPharma_2021-23 published.pdf
Setiawan, S., Hardyansah, R., Khayru, R. K., Putra, A. R., & Suwito. (2023). Consumer Protection in the Health Sector: The Legal Responsibilities of Pharmacists. Journal of Social Science Studies, 3(2), 131–138. https://jos3journals.id/index.php/jos3/article/view/262
Tubeza, P. C. (2013). Beware of Drug Stores With ‘Ghost Pharmacists.’ Philippine Daily Inquirer. https://newsinfo.inquirer.net/392041/beware-of-drug-stores-with-ghost-pharmacists
Whitchurch, G. G., & Constantine, L. L. (1993). Systems Theory BT - Sourcebook of Family Theories and Methods: A Contextual Approach. In Sourcebook of Family Theories and Methods (pp. 325–355). Springer US. https://doi.org/10.1007/978-0-387-85764-0_14
Wong, A., Perehudoff, K., & Kohler, J. C. (2024). Legislating for Good Governance in the Pharmaceutical Sector through UN Convention Against Corruption (UNCAC) Compliance. Global Public Health, 19(1), 2350649. https://doi.org/10.1080/17441692.2024.2350649
